Use of a novel chagas urine nanoparticle test (chunap) for diagnosis of congenital chagas disease.

<h4>Background</h4>Detection of congenital T. cruzi transmission is considered one of the pillars of control programs of Chagas disease. Congenital transmission accounts for 25% of new infections with an estimated 15,000 infected infants per year. Current programs to detect congenital Ch...

Full description

Saved in:
Bibliographic Details
Main Authors: Yagahira E Castro-Sesquen, Robert H Gilman, Gerson Galdos-Cardenas, Lisbeth Ferrufino, Gerardo Sánchez, Edward Valencia Ayala, Lance Liotta, Caryn Bern, Alessandra Luchini, Working Group on Chagas Disease in Bolivia and Peru
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-10-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://doi.org/10.1371/journal.pntd.0003211
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850212736889257984
author Yagahira E Castro-Sesquen
Robert H Gilman
Gerson Galdos-Cardenas
Lisbeth Ferrufino
Gerardo Sánchez
Edward Valencia Ayala
Lance Liotta
Caryn Bern
Alessandra Luchini
Working Group on Chagas Disease in Bolivia and Peru
author_facet Yagahira E Castro-Sesquen
Robert H Gilman
Gerson Galdos-Cardenas
Lisbeth Ferrufino
Gerardo Sánchez
Edward Valencia Ayala
Lance Liotta
Caryn Bern
Alessandra Luchini
Working Group on Chagas Disease in Bolivia and Peru
author_sort Yagahira E Castro-Sesquen
collection DOAJ
description <h4>Background</h4>Detection of congenital T. cruzi transmission is considered one of the pillars of control programs of Chagas disease. Congenital transmission accounts for 25% of new infections with an estimated 15,000 infected infants per year. Current programs to detect congenital Chagas disease in Latin America utilize microscopy early in life and serology after 6 months. These programs suffer from low sensitivity by microscopy and high loss to follow-up later in infancy. We developed a Chagas urine nanoparticle test (Chunap) to concentrate, preserve and detect T. cruzi antigens in urine for early, non-invasive diagnosis of congenital Chagas disease.<h4>Methodology/principal findings</h4>This is a proof-of-concept study of Chunap for the early diagnosis of congenital Chagas disease. Poly N-isopropylacrylamide nano-particles functionalized with trypan blue were synthesized by precipitation polymerization and characterized with photon correlation spectroscopy. We evaluated the ability of the nanoparticles to capture, concentrate and preserve T. cruzi antigens. Urine samples from congenitally infected and uninfected infants were then concentrated using these nanoparticles. The antigens were eluted and detected by Western Blot using a monoclonal antibody against T. cruzi lipophosphoglycan. The nanoparticles concentrate T. cruzi antigens by 100 fold (western blot detection limit decreased from 50 ng/ml to 0.5 ng/ml). The sensitivity of Chunap in a single specimen at one month of age was 91.3% (21/23, 95% CI: 71.92%-98.68%), comparable to PCR in two specimens at 0 and 1 month (91.3%) and significantly higher than microscopy in two specimens (34.8%, 95% CI: 16.42%-57.26%). Chunap specificity was 96.5% (71/74 endemic, 12/12 non-endemic specimens). Particle-sequestered T. cruzi antigens were protected from trypsin digestion.<h4>Conclusion/significance</h4>Chunap has the potential to be developed into a simple and sensitive test for the early diagnosis of congenital Chagas disease.
format Article
id doaj-art-9dca4121d4744a15ab65a88eeb12dc5f
institution OA Journals
issn 1935-2727
1935-2735
language English
publishDate 2014-10-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj-art-9dca4121d4744a15ab65a88eeb12dc5f2025-08-20T02:09:17ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352014-10-01810e321110.1371/journal.pntd.0003211Use of a novel chagas urine nanoparticle test (chunap) for diagnosis of congenital chagas disease.Yagahira E Castro-SesquenRobert H GilmanGerson Galdos-CardenasLisbeth FerrufinoGerardo SánchezEdward Valencia AyalaLance LiottaCaryn BernAlessandra LuchiniWorking Group on Chagas Disease in Bolivia and Peru<h4>Background</h4>Detection of congenital T. cruzi transmission is considered one of the pillars of control programs of Chagas disease. Congenital transmission accounts for 25% of new infections with an estimated 15,000 infected infants per year. Current programs to detect congenital Chagas disease in Latin America utilize microscopy early in life and serology after 6 months. These programs suffer from low sensitivity by microscopy and high loss to follow-up later in infancy. We developed a Chagas urine nanoparticle test (Chunap) to concentrate, preserve and detect T. cruzi antigens in urine for early, non-invasive diagnosis of congenital Chagas disease.<h4>Methodology/principal findings</h4>This is a proof-of-concept study of Chunap for the early diagnosis of congenital Chagas disease. Poly N-isopropylacrylamide nano-particles functionalized with trypan blue were synthesized by precipitation polymerization and characterized with photon correlation spectroscopy. We evaluated the ability of the nanoparticles to capture, concentrate and preserve T. cruzi antigens. Urine samples from congenitally infected and uninfected infants were then concentrated using these nanoparticles. The antigens were eluted and detected by Western Blot using a monoclonal antibody against T. cruzi lipophosphoglycan. The nanoparticles concentrate T. cruzi antigens by 100 fold (western blot detection limit decreased from 50 ng/ml to 0.5 ng/ml). The sensitivity of Chunap in a single specimen at one month of age was 91.3% (21/23, 95% CI: 71.92%-98.68%), comparable to PCR in two specimens at 0 and 1 month (91.3%) and significantly higher than microscopy in two specimens (34.8%, 95% CI: 16.42%-57.26%). Chunap specificity was 96.5% (71/74 endemic, 12/12 non-endemic specimens). Particle-sequestered T. cruzi antigens were protected from trypsin digestion.<h4>Conclusion/significance</h4>Chunap has the potential to be developed into a simple and sensitive test for the early diagnosis of congenital Chagas disease.https://doi.org/10.1371/journal.pntd.0003211
spellingShingle Yagahira E Castro-Sesquen
Robert H Gilman
Gerson Galdos-Cardenas
Lisbeth Ferrufino
Gerardo Sánchez
Edward Valencia Ayala
Lance Liotta
Caryn Bern
Alessandra Luchini
Working Group on Chagas Disease in Bolivia and Peru
Use of a novel chagas urine nanoparticle test (chunap) for diagnosis of congenital chagas disease.
PLoS Neglected Tropical Diseases
title Use of a novel chagas urine nanoparticle test (chunap) for diagnosis of congenital chagas disease.
title_full Use of a novel chagas urine nanoparticle test (chunap) for diagnosis of congenital chagas disease.
title_fullStr Use of a novel chagas urine nanoparticle test (chunap) for diagnosis of congenital chagas disease.
title_full_unstemmed Use of a novel chagas urine nanoparticle test (chunap) for diagnosis of congenital chagas disease.
title_short Use of a novel chagas urine nanoparticle test (chunap) for diagnosis of congenital chagas disease.
title_sort use of a novel chagas urine nanoparticle test chunap for diagnosis of congenital chagas disease
url https://doi.org/10.1371/journal.pntd.0003211
work_keys_str_mv AT yagahiraecastrosesquen useofanovelchagasurinenanoparticletestchunapfordiagnosisofcongenitalchagasdisease
AT roberthgilman useofanovelchagasurinenanoparticletestchunapfordiagnosisofcongenitalchagasdisease
AT gersongaldoscardenas useofanovelchagasurinenanoparticletestchunapfordiagnosisofcongenitalchagasdisease
AT lisbethferrufino useofanovelchagasurinenanoparticletestchunapfordiagnosisofcongenitalchagasdisease
AT gerardosanchez useofanovelchagasurinenanoparticletestchunapfordiagnosisofcongenitalchagasdisease
AT edwardvalenciaayala useofanovelchagasurinenanoparticletestchunapfordiagnosisofcongenitalchagasdisease
AT lanceliotta useofanovelchagasurinenanoparticletestchunapfordiagnosisofcongenitalchagasdisease
AT carynbern useofanovelchagasurinenanoparticletestchunapfordiagnosisofcongenitalchagasdisease
AT alessandraluchini useofanovelchagasurinenanoparticletestchunapfordiagnosisofcongenitalchagasdisease
AT workinggrouponchagasdiseaseinboliviaandperu useofanovelchagasurinenanoparticletestchunapfordiagnosisofcongenitalchagasdisease